Presentation is loading. Please wait.

Presentation is loading. Please wait.

Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis:

Similar presentations


Presentation on theme: "Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis:"— Presentation transcript:

1 Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis: a pooled analysis of 3 randomized clinical trials employing composite assessments  N.P. Katz, P.G. Conaghan, V.B. Kraus, J. Lufkin, J.R. Johnson, S. Kelley  Osteoarthritis and Cartilage  Volume 26, Pages S232-S233 (April 2018) DOI: /j.joca Copyright © Terms and Conditions

2 Osteoarthritis and Cartilage 2018 26, S232-S233DOI: (10. 1016/j. joca
Copyright © Terms and Conditions

3 Osteoarthritis and Cartilage 2018 26, S232-S233DOI: (10. 1016/j. joca
Copyright © Terms and Conditions


Download ppt "Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis:"

Similar presentations


Ads by Google